Henry Schein Ortho to Distribute Eversmile smartIPR

Henry Schein Orthodontics has entered into an exclusive U.S. distribution agreement for the Eversmile smartIPR interproximal reduction system. The partnership introduces an oscillation-based platform designed to replace traditional, high-risk manual tools with a more controlled chairside solution. This collaboration highlights the dental industry's move toward technology-driven efficiency and improved patient safety in orthodontic procedures.

Henry Schein Orthodontics (HSO) officially announced its exclusive U.S. distribution agreement with Eversmile on July 6, 2026, for the smartIPR interproximal reduction system. The platform is designed to modernize a chairside category that has traditionally relied on hand strips and spinning disks, which often pose a higher risk of tissue trauma. By utilizing a vibrating handpiece and non-rotating, lubricated smart DISKS, the system allows clinicians to open tight interproximal contacts gradually and with greater precision than legacy methods.

Zachary Meli, Vice President and General Manager at HSO, stated that the deal expands the company's offering of clinically driven solutions to enhance orthodontic efficiency and the overall patient experience. Dr. Michael Florman, President and CEO of Eversmile, indicated that the smartIPR system has already generated significant clinician interest and that HSO’s extensive distribution reach will materially expand access to the technology. The system is engineered to integrate into existing chairside workflows without disrupting established treatment protocols, making it a versatile addition for practitioners.

The addition of smartIPR strengthens HSO’s portfolio of specialist brands, which currently includes Carriere Motion, Ortho Technology, Smilers, and Nemotec. This aggregation strategy is intended to help HSO compete more directly with major industry rivals such as Ormco and 3M. As aligner-driven treatment plans continue to increase the demand for IPR, the market is shifting toward system-based platforms that offer clearer clinical safety profiles and reduced clinician variability. This commercial signal suggests a broader move within the dental sector toward procurement priorities that favor patient comfort and technological innovation.